VCEL
Vericel Corporation
NASDAQ · Healthcare · Biotechnology · US
$40.19
−0.69%Forward multiples
Based on analyst estimates
- P/E forward
- 57.26x
- P/E 2026E
- 75.19x
- P/E 2027E
- 46.44x
- P/E 2028E
- 30.08x
- P/S forward
- 5.70x
Trailing multiples
Trailing twelve months
- P/E TTM
- 83.73x
- PEG TTM
- 1.81x
- Price / book
- 5.56x
- Price / sales
- 6.72x
- Price / cash flow
- 29.54x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- 6.49x
- EV / EBITDA
- 51.70x
- EV / EBIT
- 109.03x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026